Study revealing a novel regulatory mechanism of ER-membrane protein complex in #HepatocellularCarcinoma progression through lipid metabolism 👉 https://t.co/mtRcTf16eY

Did you know that HOMER3 plays a key role in oral squamous cell carcinoma progression and drives chemoresistance? https://t.co/ckeA3vIk1V #OSCC

Read about the crucial role of XLH-36, a micropeptide, in Triple-negative #BreastCancer metastasis here: https://t.co/enGz50Ecea

New research uncovers FRA1 as a key driver of melanoma metastasis—revealing actionable targets like AXL, CDK6, and FSCN1 that could pave the way for new cancer therapies. https://t.co/CEKo15NMS0

Latest study reveals that a novel SN38-PROTAC targeting RPL15 boosts anti-PD-1 immunotherapy by activating cGAS-STING signaling and enhancing tumor immunity with minimal toxicity. Read more about this new research >>

Online now: New research reveals how the enzyme SQLE fuels #bladder cancer by rewiring mitochondrial metabolism—and shows that an existing FDA-approved drug could help stop it. #CancerResearch #BladderCancer https://t.co/NX0DfOuoDl

New study reveals that circCLASP1 drives #breast cancer progression and immune evasion by stabilizing GLI1, highlighting its promise as a novel biomarker and therapeutic target. Available to read >>> https://t.co/XgkDvKDc1h

New research uncovers how the HBx-KLF16-C12orf49-PD-L1 axis drives growth and immune evasion in HBV-related liver cancer—revealing a potential new target to enhance anti-PD-L1 therapy in HCC. #LiverCancerResearch #Immunotherapy https://t.co/Qwvayr625k

New study reveals that chaperone-mediated autophagy fuels breast #cancer progression by enhancing the cross talk between tumor and endothelial cells. #CancerResearch #Autophagy #Angiogenesis https://t.co/MG7vGzOtYH

Latest study reveals that the PML-mTOR-RONIN complex regulates ribosomal protein genes to control senescence in triple-negative breast cancer, offering fresh insights into senescence-targeted therapies. #CancerResearch #TNBC https://t.co/GCDc7mCTPg

New research shows that blocking key survival pathways may finally open the door to effective treatments for NF2-related schwannomatosis—a rare genetic condition long without drug options. Read more 📖 now >>> https://t.co/SDFBDvOe8q

Whole-genome sequencing transforms metastatic colorectal cancer care. Latest study shows WGS identifies new biomarkers, doubling access to personalized, biomarker-based treatments. Discover how genomics and organoid testing redefine precision oncology. https://t.co/dYzvlU2Ms9

WBP11-driven suppression of NONO UFMylation unveils a previously unrecognized regulatory axis that fuels #hepatocellular carcinoma progression, offering new therapeutic avenues in targeting posttranslational modification dynamics! Read now 🧬🧫🔬 https://t.co/KPSgIJC4Ix

Could histamine H1 receptor, HRH1, be the new target for treating #glioblastoma? https://t.co/0KwYW1e6gV #GBM

A novel, non-genetic mechanism to inhibit #apoptosis Read here 👉 https://t.co/s9H9QpUu9Q #OpenAccess #CancerResearch

New study identifies Meflin as a promising target in refractory 🦴#osteosarcoma and presents a novel antibody-drug conjugate therapy showing high efficacy in preclinical models. https://t.co/cGs3Gh6iAC @esaki_nobutoshi

hnRNPM supresses proliferation of colorectal carcinoma through regulation of #splicing https://t.co/HglmA3iyGE

Delving into the role of the ATM-ZDHHC20-KAP1 axis in 🧬DNA damage repair https://t.co/qiTVj6EebJ #DDR #CancerResearch

Hot off the press from @itsTaps & co-workers 👉Circadian disruption alters mammary gland morphology https://t.co/UpQ6V7ng69 #BreastCancer #OpenAccess

Could targeting BRD4 be a viable strategy to augment the efficacy of #radiotherapy for🧠#glioblastoma treatment? https://t.co/efn5x88yBe